title: Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy.
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Cassano
authors.forename: Carmela
authors.initials: C
authors.lastname: Coviello
authors.forename: Francesco
authors.initials: F
authors.lastname: Loconsole
authors.forename: Antonio
authors.initials: A
authors.lastname: Miracapillo
authors.forename: Gino Antonio
authors.initials: GA
authors.lastname: Vena
mesh_terms: D000328:Adult; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011565:Psoriasis / Q000188:drug therapy / Q000503:physiopathology*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept